Mark L Perry's Net Worth
$50.3 Million
Who is Mark L Perry?
Mark L Perry has an estimated net worth of $50.3 Million. This is based on reported shares across multiple companies, which include NVIDIA CORP, Global Blood Therapeutics, Inc., MyoKardia Inc, GILEAD SCIENCES INC, NUVELO INC, and INTRABIOTICS PHARMACEUTICALS INC /DE.
SEC CIK
Mark L Perry's CIK is 0001190270
Past Insider Trading and Trends
2020 was Mark L Perry's most active year for acquiring shares with 18 total transactions. Mark L Perry's most active month to acquire stocks was the month of May. 2020 was Mark L Perry's most active year for disposing of shares, totalling 37 transactions. Mark L Perry's most active month to dispose stocks was the month of January. 2011 saw Mark L Perry paying a total of $1,482,250.00 for 210,000 shares, this is the most they've acquired in one year. In 2018 Mark L Perry cashed out on 17,307 shares for a total of $3,944,805.28, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NVIDIA CORP (NVDA) Snapshot price: $102.49
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| -5.69% | -7.00K |
$887.89 | -$6,215,259.40 | 116K |
Apr 2
| |||
Form 4
| -10.87% | -15.00K |
$796.45 | -$11,946,691.50 | 123K |
Feb 23
| |||
Form 4
| +5.01% | 650 |
—
|
—
| 13.61K |
Jun 23
| |||
Form 4
|
—
|
0
|
—
|
—
| 140K |
May 26
| |||
Form 4
| -12.50% | -20.00K |
$236.37 | -$4,727,428.01 | 140K |
Feb 27
| |||
Form 4
| +12.48% | 1.44K |
—
|
—
| 12.96K |
Jun 3
| |||
Form 4
| -59.19% | -16.72K |
$263.80 | -$4,409,698.72 | 11.52K |
Mar 18
| |||
Form 4
| +6.47% | 429 |
—
|
—
| 7.06K |
Jun 4
| |||
Form 4
| -47.93% | -6.10K |
$556.58 | -$3,397,359.84 | 6.63K |
Apr 5
| |||
Form 4
| +5.92% | 712 |
—
|
—
| 12.73K |
Jun 10
| |||
Form 4
| -50.38% | -12.21K |
$333.31 | -$4,069,049.26 | 12.02K |
May 27
| |||
Form 4
| -26.53% | -8.75K |
$292.13 | -$2,556,746.85 | 24.23K |
Feb 18
| |||
Form 4
| +3.97% | 1.26K |
—
|
—
| 32.98K |
May 23
| |||
Form 4
| +3.13% | 963 |
—
|
—
| 31.73K |
May 17
| |||
Form 4
| -36.00% | -17.31K |
$227.93 | -$3,944,805.28 | 30.76K |
Feb 12
| |||
Form 4
| -25.30% | -16.28K |
$162.24 | -$2,641,369.20 | 48.07K |
Aug 14
| |||
Form 4
| -7.07% | -7.94K |
—
|
—
| 104.35K |
Mar 6 - May 24
| |||
Form 4
|
—
|
0
|
$35.36 | -$1,230,162.50 | 62.29K |
Jul 13
| |||
Form 4
| +11.08% | 6.21K |
—
|
—
| 62.29K |
May 19
| |||
Form 4
|
—
|
0
|
$21.48 | -$721,304.00 | 56.08K |
Nov 12
| |||
Form 4
| +22.45% | 10.28K |
—
|
—
| 56.08K |
May 21
| |||
Form 4
|
—
|
0
|
$15.93 | -$601,339.20 | 45.8K |
Feb 18
| |||
Form 4
| +36.35% | 12.21K |
—
|
—
| 45.8K |
May 27
| |||
Form 4
|
∞
| 17.31K |
—
|
—
| 17.31K |
May 16
| |||
Form 4
| +32.56% | 16.28K |
—
|
—
| 66.28K |
May 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 19
| |||
Form 4
|
—
|
0
|
$12.94 | -$1,564,080.00 | 50K |
Apr 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
∞
| 50K |
$8.47 | $423,500.00 | 50K |
Jan 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Global Blood Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -37.87K |
—
|
—
|
0
|
Oct 5
| |||
Form 4
| +10.51% | 3.6K |
—
|
—
| 37.87K |
Jun 14
| |||
Form 4
| +9.73% | 3.04K |
—
|
—
| 34.27K |
Jun 17
| |||
Form 4
| +18.16% | 4.8K |
—
|
—
| 31.23K |
Jun 17
| |||
Form 4
|
—
|
0
|
$50.07 | -$3,004,560.61 | 26.43K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +23.33% | 5K |
$20.00 | $100,000.00 | 26.43K |
Aug 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
MyoKardia Inc No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -29.51K |
—
|
—
|
0
|
Nov 17
| |||
Form 4/A
| +9.05% | 2.3K |
—
|
—
| 27.71K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| +9.05% | 2.3K |
—
|
—
| 27.71K |
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 4
| +24.50% | 5K |
$10.00 | $50,000.00 | 25.41K |
Nov 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
GILEAD SCIENCES INC (GILD) Snapshot price: $78.52
EVP Operations
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +1.15% | 2.28K |
$35.68 | -$2,046,121.04 | 201.64K |
Feb 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
$34.53 | -$1,754,122.80 | 194.04K |
Oct 31
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +6.39% | 11.66K |
$38.58 | -$2,566,541.80 | 194.04K |
Aug 5 - Aug 6
| |||
No matching records found |
NUVELO INC (ABIO) Snapshot price: $2.48
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
|
∞
| 65.83K |
$9.07 | $596,989.46 | 65.83K |
Sep 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |